Nuchev Pty Ltd (AU:NUC)
ASX:NUC
Want to see AU:NUC full AI Analyst Report?
NUC Stock Chart & Stats
AU$0.12
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.12
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.10 - AU$0.23
Previous CloseN/A
Volume11.15K
Average Volume (3M)7.76K
Market Cap
AU$21.95M
Enterprise ValueAU$15.46M
Total Cash (Recent Filing)AU$3.11M
Total Debt (Recent Filing)AU$529.14K
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding156,818,770
10 Day Avg. Volume3,027
30 Day Avg. Volume7,761
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.82
Price to Sales (P/S)0.89
P/FCF Ratio-5.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained high revenue growth indicates the Olli brand is gaining traction and distribution. For a consumer-health business, continued top-line momentum supports scale economics, potential gross margin leverage, and provides a foundation to fund marketing, R&D or geographic expansion as operations mature.
Low LeverageA conservative debt profile gives the company financial flexibility while it works to fix profitability and cash generation. Low leverage reduces refinancing risk and preserves capacity to invest in inventory, marketing, or channel growth without immediate pressure from interest obligations.
Brand & Multi-channel ModelA branded consumer-health product in infant and children categories benefits from recurring demand and strong customer lifetime value. Having both wholesale (retail/pharmacy) and direct-to-consumer channels diversifies revenue, supports scale, and enables data-driven product and marketing strategies over the medium term.
Bears Say
Persistent UnprofitabilityDespite healthy sales growth, ongoing negative EBIT and net margins indicate structural issues in cost base, pricing, or unit economics. Without a credible path to sustainable operating profitability, long-term viability depends on either margin recovery or continued external funding.
Negative Operating & Free Cash FlowOngoing cash burn constrains the firm's ability to self-fund growth, restock inventory, and invest in brand building. Persistent negative operating and free cash flow increases reliance on external financing, which can dilute equity or limit strategic options if capital markets tighten.
Negative Return On EquityNegative ROE shows the company is not delivering shareholder returns despite an asset base and revenue growth. Over time this limits access to cheap capital, raises governance pressure, and signals that operational improvements are needed to convert growth into value for investors.
Nuchev Pty Ltd News
NUC FAQ
What was Nuchev Pty Ltd’s price range in the past 12 months?
Nuchev Pty Ltd lowest share price was AU$0.10 and its highest was AU$0.23 in the past 12 months.
What is Nuchev Pty Ltd’s market cap?
Nuchev Pty Ltd’s market cap is AU$21.95M.
When is Nuchev Pty Ltd’s upcoming earnings report date?
Nuchev Pty Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 106 days.
How were Nuchev Pty Ltd’s earnings last quarter?
Nuchev Pty Ltd released its earnings results on Feb 24, 2026. The company reported -AU$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.02.
Is Nuchev Pty Ltd overvalued?
According to Wall Street analysts Nuchev Pty Ltd’s price is currently Overvalued.
Does Nuchev Pty Ltd pay dividends?
Nuchev Pty Ltd does not currently pay dividends.
What is Nuchev Pty Ltd’s EPS estimate?
Nuchev Pty Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuchev Pty Ltd have?
Nuchev Pty Ltd has 156,818,770 shares outstanding.
What happened to Nuchev Pty Ltd’s price movement after its last earnings report?
Nuchev Pty Ltd reported an EPS of -AU$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nuchev Pty Ltd?
Currently, no hedge funds are holding shares in AU:NUC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nuchev Pty Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.34%
12-Months-Change
Fundamentals
Return on Equity
-41.69%
Trailing 12-Months
Asset Growth
-1.10%
Trailing 12-Months
Company Description
Nuchev Pty Ltd
Nuchev Limited, a health and nutrition solutions company, produces, markets, and sells goat milk-based infant formula and nutritional products to consumers in Australia, China, and Vietnam. The company provides toddler nutrition, goat nutritional powder, and health and well-being products under the Oli6 brand. It offers its products through retailers and e-commerce platforms. Nuchev Limited was founded in 2013 and is headquartered in Melbourne, Australia.
Technical Analysis
Noumi Limited
―
Australian Dairy Nutritionals Group
―
Wellnex Life Ltd
―
―
Maggie Beer Holdings Ltd.
―
Options Prices
Currently, No data available
---